Viewing Study NCT03646968


Ignite Creation Date: 2025-12-24 @ 5:58 PM
Ignite Modification Date: 2026-01-28 @ 8:04 PM
Study NCT ID: NCT03646968
Status: RECRUITING
Last Update Posted: 2023-12-27
First Post: 2018-08-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Anlotinib Combined With Docetaxel in Non-Driver Mutation Non-squamous NSCLC: the Save Study
Sponsor: Yongchang Zhang
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Squamous Non Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anlotinib Combined With Docetaxel View